A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and PerSiStence with Inflammatory Bowel DiSease Therapy ASSIST Study

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
  • Age: Between 18 Year(s) - 100 Year(s)
  • Gender: Male or Female
  • Other Inclusion Criteria:
    1. At least 18 years of age or older.
    2. Have documented inflammatory bowel disease (IBD) based on usual diagnostic criteria including clinical symptoms and findings from endoscopy, radiology studies, and histology.
    3. Initiating treatment with a new oral or subcutaneous treatment for IBD.
    4. Have access to a mobile smartphone (iPhone 7 or later; Android release date 2012 or later) with reliable data and/or Wi-Fi access.
    5. Ability to understand the protocol and provide informed consent in English.

You may not be eligible for this study if the following are true:

    1. Inability to speak and read English.
    2. Inability to comply with the study protocol.
    3. Presence of an ileostomy, colostomy, ileoanal pouch anastomosis, or ileorectal anastomosis.
    4. Patients initiating oral corticosteroids only (without concurrent use of an oral or subcutaneous maintenance therapy).
    5. Imminent surgery (within the next 60 days).
    6. History of short bowel syndrome.
    7. Degenerative neurologic condition.
    8. Unstable angina.
    9. Symptomatic peripheral vascular disease.
    10. Malignancy within the last 2 years (excluding squamous or basal cell cancers of the skin).
    11. Poorly controlled depression, mania, and schizophrenia.
    12. Serious active infection requiring antimicrobial therapy (excluding Crohn’s disease (CD) patients with perianal CD on antibiotics).

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.